Summary: Arginase activity of the intestinal mucosa was tested as a proliferative marker in the adenoma-carcinoma sequence. The enzyme activity was determined by an end-point colorimetric method with L-arginine as substrate. Arginase activity was evaluated in 430 biopsy samples of large bowel mucosa, polyps and cancer tissue. The activities (U/g protein, mean ± SE; n) were: normal mucosa 83. 2 ± 7.3; 25, adenomas 199.4 ± 19
Introduction
Tumour markers may provide a valuable tool for the screening and early detection of colorectal neoplasia. Determination of proliferative markers could be used for evaluation of the malignancy risk in 'high-risk' individuals. Activities of enzymes involved in tumour cell differentiation and proliferation were tested for this reason. Ornithine decarboxylase (1, 2), urokinasetype plasminogen activator (3, 4) , cathepsin B (5, 6), tyrosine kinase (1)" glutathione S-transferase (7), protein kinase C (8-10), sucrase-isomaltase (11, 12) , alkaline phosphatase (13) , lactate dehydrogenase (14) and in the last years also arginase (15, 16) activities were reported. In a previous paper we reported a significant correlation of the M/H monomer ratio of lactate dehydrogenase in the colonic mucosa with the adenoma-carcinoma sequence (17) . The aim of this study was to evaluate arginase activity as a proliferative marker of colorectal mucosa under normal and pathological conditions.
Materials and Methods

Tissue specimens
Arginase activity was evaluated in a total of 210 patients who underwent endoscopic polypectomy or biopsy at the Department of Medicine, Faculty Clinics, Prague. The following groups were established according to histologic examination: colon cancer (n = 40), adenomatous polyps (n = 40), inflammatory bowel disease (n = 34), post-resection anastomosis (n = 17), controls with normal histology (n = 25). Fourty-four cases remained nongrouped.
Reproducibility, variations and heterogeneity of arginase determination were studied on 3 cases.
Case A -normal mucosa; 10 biopsies were taken from the distal part of colon; case Β -large adenomatous polyp; 43 mm was cut into 10 parts; case C -broad sessile polyp; 10 biopsy samples were taken from the lesion.
The proximodistal gradient of arginase activity was studied in the group of 11 patients with segmental biopsies along the large bowel. The following localizations were described: caecum; ascending colon; colon transversum; descending colon; sigmoid; rectum ( fig.  1 ). Only 7 patients with all six tested localizations were used for final evaluation.
Biopsy sample preparation
Tissue samples of mucosa, polyps or cancers of the large bowel were obtained endoscopically during colonoscopy using the biopsy forceps (Olympus Type FB-24 U) or as a part of polyps removed by polypectomy. Tissue samples were immediately frozen on dry ice and stored at -75 °C (UltraLow BioFreezer, Forma Scientific, USA).
Colon transversum
Colon ( ascendens Biopsy samples were homogenized in 5 mmol Tris-HCl buffer (pH 7.5) containing 100 μηιοΐ/ΐ MnCl 2 by using of a glass-homogenizer for 1 minute in ice-water bath. The homogenized material was centrifuged at 18000 min" 1 for 60 min (refrigerated Janetzki K-24 centrifuge, 4 °C) and the supernatant was used for enzyme activity assay.
Arginase activity assay
The enzyme activity was determined by our modification of the procedure described by Konarska (18, 19) . Reagent stock solutions were: 100 mmol/1 arginine (fresh every day), 2 mmol/1 omithine (stable one month at 4 °C), 25 g/1 ninhydrin (Merck, Germany) in 10 mol/1 acetic acid/2.4 mol/1 phosphoric acid (stable for several months), 10 mmol/1 MnCl 2 (stable for one month).
The incubation of samples was carried out in a water-bath (Lauda, Germany) at 37 °C for 120 minutes and stopped by immersing tubes in a boiling water-bath for 5 minutes. The reaction conditions were as follows: 500 μΐ of 35 mmol/1 Tris-HCl buffer pH 9.5-20 mmol/1 arginine-1 mmol/1 MnCl 2 were incubated with 25 μΐ of homogenate and 25 μΐ of 5 mmol/1 Tris-HCl buffer. The ornithine concentration was determinated by an end-point ninhydrin reaction, carried out in a boiling water bath for 60 minutes. Ninhydrin reagent (0.5 ml) and acetic acid (1.5 ml) were added to the incubation medium. This reaction was stopped by cooling to room-temperature and the colored reaction product was evaluated by using a double-beam spectrophotometer CE 5000 (Cecil, UK) at 515 nm in a 1 cm glass cuvette.
Optimal arginine concentration was evaluated from 60 measurements of 5 patients (covering all groups) and arginine concentrations in the range 5-200 mmol/1 (stock solutions) were processed in duplicate.
Ornithine concentration was calculated from calibration standards (0.5-2.0 mmol/1 processed with every sample batch. A sample blank was processed without the 120 minute incubation period for each test. Wavelength scan was obtained by using a DU-8B spectrophotometer (Beckman, USA) in the range of 350-750 nm (scan speed 100 nm/min).
Arginase activity was expressed in micromoles of ornithine per minute per gram protein [U/g]. Soluble protein was determined by the Lowry method using bovine albumin as a calibration protein.
Statistical evaluation
Results were evaluated by the analysis of variance, Student's test and Duncan's test (procedures ANOVA, MANOVA) using the statistical package SPCC PC+ (version 3.1) on a personal computer. With respect to the asymmetric distribution of data, their logarithmic values were used for the determination of Duncan's test.
Results
Arginase colorimetric method
Arginase activity in tissue samples was determined by a two-step method. The first enzymatic reaction produces L-ornithine from Ζ,-arginine. The concentration of ornithine is measured by a colorimetric method with ninhydrin. Wavelength scan of the dye produced by the reaction with ninhydrin showed a peak with a maximum at 512 nm ( fig. 2 ).
The calibration curve in the range 0-2 mmol/1 of ornithine ( fig. 3 ) is linear and the reaction product is not influenced by MnCl 2 used for enzyme activation. The variance of 0.37% was calculated from a total of 60 measurements (10 times of 6 standards). 
Clinical significance of arginase activity
The arginase activity (mean ± SE) in five groups ( fig. 6 ) -colorectal cancer, adenomatous polyps, inflammatory bowel disease, postresection anastomosis and controls were 1269.7 ± 174.9, 199.4 ± 19.2, 1210.7 ±247.1, 217.9 ± 110.0, and 83.2 ± 7.3 U/g of protein, respectively. The statistical analysis of variances [Duncan's test] displayed significant difference between the group of normal mucosa and all pathological groups (p < 0.05) as well as between the groups of colorectal cancer and inflammatory bowel disease and the groups with adenomas and mucosa of the postresection anastomosis (p < 0.05).
Discussion
Cancer development represents a very complex process involving different stages defined by biochemical and histopathological events (20) . Several biochemical tumour markers (21) have been tested to support tumour differential diagnosis, follow-up and early cancer detection. Proteinases, like cathepsin B, D or plasminogen activator, have been proposed to participate in the metastatic cascade. Ornithine decarboxylase, one of the rate-limiting enzymes in the polyamine pathway, polyamines themselves (putrescine, spermidine, spermine and cadaverine) have an essential role in cell proliferation (22) . Immunochemical and immunohistochemical methods are used to prognosticate the risk of cancer reccurence (23, 24) . The common main goal of all of these techniques and methods is to distinguish between normal, proliferating and carcinomatous mucosa.
Arginase (L-arginine amidinohydrolase, EC 3.5.3.1) converts L-arginine into L-ornithine and urea. The elevated activity of arginase has been reported in serum as well as in tissues in colorectal (16, 25, 26) , gastric (15) and mammary (27) carcinomas. The ELISA assay was developed to evaluate arginase plasma levels (28) . This study was designed to investigate methodological aspects of arginase activity determination in the biopsy sample tissue of colonic mucosa.
Arginase activity in the colonic mucosa is determined by a two-step method according to Konarska (18, 19) . The concentration of ornithine (as a product of the first reaction) is measured by a colorimetric method with ninhydrin. We confirmed conditions for the colorimetric assay by wavelength scan of the end-product and linearity of the calibration curve. Manganese chloride used to activate the enzymatic activity (29, 30) did not affect the assay linearity. Variations of the ornithine concentration measurement were found to be less than 1%.
We found no differences in arginase activity along the large bowel, i.e. there is no proximodistal gradient of this enzyme in the colonic mucosa. The reproducibility of the arginase assay in the mucosal samples is considerably influenced by the cell heterogeneity of the tissue sample. In the normal mucosa the variation amounted to ± 19.9% of the mean activity, in adenomatous polyps this variation was much higher due to higher cell heterogeneity.
High arginase activity was found in the group of colorectal cancer and inflammatory bowel disease. This corresponds well with the endeavor to use arginase as a proliferative marker for colonic mucosa. The significant differences were found between normal and pathologically changed mucosa, and between tissue with higher proliferation (cancer and inflammatory disease) and adenomatous polyps or post-resection mucosa in the large bowel anastomosis. Further studies are aimed at the diagnostic efficiency of arginase activity of the colonic mucosa and at the distribution of this activity in mucosa surrounding neoplastic lesions.
